Adaptive Biotechnologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.

CEO

Chad Robins

CEOChad Robins

Employees

619

Employees619

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2009

Founded2009

Employees

619

Employees619

ADPT Key Statistics

Market cap

1.29B

Market cap1.29B

Price-Earnings ratio

-7.98

Price-Earnings ratio-7.98

Dividend yield

—

Dividend yield—

Average volume

2.12M

Average volume2.12M

High today

$8.61

High today$8.61

Low today

$8.61

Low today$8.61

Open price

$8.57

Open price$8.57

Volume

1.16K

Volume1.16K

52 Week high

$9.01

52 Week high$9.01

52 Week low

$2.28

52 Week low$2.28

ADPT News

Seeking Alpha 4d

Adaptive Biotech rises as Goldman Sachs upgrades on market dynamics

Shares of Adaptive Biotechnologies (NASDAQ:ADPT) climbed in the morning hours on Friday after Goldman Sachs upgraded the stock to Buy from Neutral, arguing that...

TipRanks 4d

Adaptive Biotechnologies upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Salveen Richter upgraded Adaptive Biotechnologies (ADPT) to Buy from Neutral with a $9 price target Since October 2024, Adaptive has put e...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell